Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Wei‐Guang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3442-7518; OpenAlex author ID A5007980901. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper

Papers 2

  1. Effect of p53 on pancreatic cancer-glucose tolerance abnormalities by regulating transglutaminase 2 in resistance to glucose metabolic stress. Co-author DOI 10.18632/oncotarget.19402↗
  2. Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells. Co-author DOI 10.1016/j.diabres.2011.12.028↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yaozong Yuan · 2 shared papers, 2012–2017 · strength 0.10
  2. Xiao Hua Su · 1 shared paper, 2017 · strength 0.06
  3. Ping Chen · 1 shared paper, 2017 · strength 0.06
  4. Qiwen Ben · 1 shared paper, 2017 · strength 0.06
  5. Xiangyi He · 1 shared paper, 2017 · strength 0.06
  6. Yi Zang · 1 shared paper, 2017 · strength 0.06
  7. Weiyan Yao · 1 shared paper, 2017 · strength 0.06
  8. Yongping Zhang · 1 shared paper, 2012 · strength 0.04
  9. Liya Huang · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.